In this issue:
Underlying mechanisms for reduced exercise tolerance in mild COPD
SVC vs FVC for measuring COPD via spirometry
Haemoglobin as a biomarker for clinical outcomes in COPD
Long-term particulate matter exposure and cardiovascular risk in adults with COPD
Chronic bronchial infection and incident cardiovascular events
A pharmacist-led intervention improves inhalation technique
Efficacy of budesonide/glycopyrronium/ formoterol MDI in patients with COPD
ICS use does not cause hyperglycaemia-related adverse events
Impact of COVID-19 lockdowns on health status in patients with COPD
Benefits of PR in COPD patients with mild cognitive impairment
Please login below to download this issue (PDF)